Chinese English Japanese Germany Korea
ChemicalBook >제품 카탈로그 >Vecabrutinib

Vecabrutinib

Vecabrutinib 구조식 이미지
카스 번호:
1510829-06-7
상품명:
Vecabrutinib
동의어(영문):
Vecabrutinib;Vecabrutinib(SNS-062);Vinflunine Impurity 11;(3R,3'R,4'S)-1'-(6-Amino-5-fluoropyrimidin-4-yl)-3-((3-chloro-5-(trifluoromethyl)phenyl)amino)-2-oxo-[1,3'-bipiperidine]-4'-carboxamide;[1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3R,3'R,4'S)-
CBNumber:
CB44668642
분자식:
C22H24ClF4N7O2
포뮬러 무게:
529.92
MOL 파일:
1510829-06-7.mol

Vecabrutinib 속성

끓는 점
776.0±60.0 °C(Predicted)
밀도
1.509±0.06 g/cm3(Predicted)
저장 조건
Store at -20°C
용해도
DMSO : 125 mg/mL (235.88 mM)
산도 계수 (pKa)
16.01±0.40(Predicted)

안전

Vecabrutinib C화학적 특성, 용도, 생산

용도

Vecabrutinib is used in biological studies of Burton’s Tyrosine Kinase (BTK) inhibitors.

Vecabrutinib 준비 용품 및 원자재

원자재

준비 용품

Vecabrutinib 공급 업체

글로벌( 35)공급 업체
공급자 전화 이메일 국가 제품 수 이점
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
Zibo Hangyu Biotechnology Development Co., Ltd 		+86-0533-2185556 +8617865335152
 Mandy@hangyubiotech.com China 11013 58
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
 sales-cpd@caerulumpharma.com China 3427 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696，15000506266 15000506266
 China 4182 55
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 4009686088
 3193328036@qq.com China 29796 68
Changzhou Yongfeng Biomedicine Co. Ltd. 15006117673
 2973592490@qq.com China 310 58
Amel Pharmatech Corporation 888-4366503
sales@amelpharmatech.com China 5351 58
Jiangsu yize medical technology co. LTD 18550739526
 23903480@qq.com China 5841 58
Wuxi Donghe Pharmaceutical Technology Co., Ltd. 63313187 15358055255
 63313187@qq.com China 1938 58

Vecabrutinib 관련 검색:

Ceritinib (LDK378) Ibrutinib (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3S,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo[1,3′-bipiperidine]-4′-carboxamide (3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N,N-dimethyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylthio)phenyl)furan-3(2H)-one 4-(5,5-dimethyl-4-oxo-3-phenyl-4,5-dihydrofuran-2-yl)benzenesulfonamide (3S,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide rel-(3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide [1,3'-Bipiperidine]-4'-carboxamide, 1'-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3S,3'R,4'S)- 3(2H)-Furanone, 5-[4-[[(acetyloxy)methyl]thio]phenyl]-4-(3-fluorophenyl)-2,2-dimethyl- 4-(2,5-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 4-(4-fluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one 2,2-dimethyl-5-(4-(methylthio)phenyl)-4-phenylfuran-3(2H)-one (3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide 4-(3,4-difluorophenyl)-2,2-dimethyl-5-(4-(methylsulfonyl)phenyl)furan-3(2H)-one (3R,3′S,4′R)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-N-methyl-2-oxo[1,3′-bipiperidine]-4′-carboxamide
Copyright 2019 © ChemicalBook. All rights reserved